Logo of Actinogen Medical (ASX:ACW)Latest Actinogen Medical (ASX:ACW) News

Page 5
Page 5 of 5

Actinogen Validates 10 mg Xanamem Dose in Peer-Reviewed Clinical Study

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.
Ada Torres
6 Feb 2025

Actinogen Advances Alzheimer's Trial with $22.9M Cash Boost

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.
Ada Torres
29 Jan 2025